NervGen Pharma Corp. Common stock logo

NervGen Pharma Corp. Common stock

NGEN | NASDAQ
Chart Builder DCF Calculator
$1.41
+$0.04 (+2.92%)
Nov 2, 2026, 11:20 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Cash & Equivalents
22.07M 17.26M 11.66M 22.25M 17.06M 5.61M
Short-Term Investments
n/a 97.17K n/a n/a n/a n/a
Long-Term Investments
n/a 8.36K n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a
Receivables
80.83K 415.02K 250.23K 26.79K 64.49K 62.73K
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
8.37K 1.02M 388.04K 525.32K 313.36K 456.49K
Total Current Assets
22.8M 19M 12.52M 22.94M 17.55M 6.22M
Property-Plant & Equipment
n/a n/a 199.8K 292.68K 2.71K 2K
Goodwill & Intangibles
409.16K 464.65K 520.8K 427.61K 476.75K 472.45K
Total Long-Term Assets
409.16K 473.01K 720.59K 720.29K 479.46K 474.45K
Total Assets
23.21M 19.47M 13.24M 23.67M 18.03M 6.69M
Account Payables
4.66M n/a n/a n/a n/a n/a
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a 97.17K 91.59K 85.51K n/a n/a
Other Current Liabilities
15.07M 15.63M 14.61M 9.54M 1.09M 756.78K
Total Current Liabilities
19.73M 16.89M 15.14M 10.13M 1.09M 756.78K
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
n/a 8.36K 105.61K 195.46K n/a n/a
Total Liabilities
19.73M 16.9M 15.25M 10.32M 1.09M 756.78K
Total Debt
8.37K 105.53K 197.21K 280.96K n/a n/a
Book Value
3.48M 2.57M -2.01M 13.34M 16.95M 5.93M
Book Value Per Share
0.05 0.04 -0.03 0.25 0.43 0.18
Common Stock
103M 81.05M 58.94M 56.91M 42.73M 23M
Retained Earnings
-146.76M -102.09M -78.16M -55.28M -35.32M -22.37M
Comprehensive Income
n/a 23.62M 17.21M 11.72M 9.54M 5.31M
Shareholders Equity
3.48M 2.57M -2.01M 13.34M 16.95M 5.93M
Total Investments
n/a 105.53K n/a n/a n/a n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.